Responses

Download PDFPDF

Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Corrigendum

    It is worth noting that 'RR' in the title of our article is indeed 'relative risk' but that there is no statistical inference associated with our use of this term.

    Also, I am grateful to Ross Bearman and others for pointing out some typos / errors in our paper - namely: The introduction states cannabis is a class C drug, the correct designation of class B is listed in table 1.

    Figure 2 identifies methyl...

    Show More
    Conflict of Interest:
    None declared.